Hofseth BioCare Past Earnings Performance
Past criteria checks 0/6
Hofseth BioCare's earnings have been declining at an average annual rate of -8.7%, while the Biotechs industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 26.7% per year.
Key information
-8.7%
Earnings growth rate
-1.7%
EPS growth rate
Biotechs Industry Growth | 17.0% |
Revenue growth rate | 26.7% |
Return on equity | -259.3% |
Net Margin | -48.8% |
Next Earnings Update | 16 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Hofseth BioCare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 219 | -107 | 76 | 0 |
30 Sep 23 | 205 | -93 | 78 | 0 |
30 Jun 23 | 185 | -105 | 77 | 0 |
31 Mar 23 | 134 | -140 | 76 | 0 |
31 Dec 22 | 120 | -137 | 76 | 0 |
30 Sep 22 | 113 | -136 | 66 | 0 |
30 Jun 22 | 96 | -139 | 64 | 0 |
31 Mar 22 | 102 | -135 | 63 | 0 |
31 Dec 21 | 88 | -126 | 60 | 0 |
30 Sep 21 | 85 | -120 | 44 | 0 |
30 Jun 21 | 79 | -115 | 47 | 0 |
31 Mar 21 | 68 | -111 | 45 | 0 |
31 Dec 20 | 69 | -102 | 43 | 0 |
30 Sep 20 | 57 | -104 | 46 | 0 |
30 Jun 20 | 79 | -90 | 37 | 0 |
31 Mar 20 | 72 | -86 | 36 | 0 |
31 Dec 19 | 68 | -89 | 34 | 0 |
30 Sep 19 | 71 | -79 | 41 | 0 |
30 Jun 19 | 59 | -81 | 42 | 0 |
31 Mar 19 | 61 | -83 | 42 | 0 |
31 Dec 18 | 61 | -85 | 43 | 0 |
30 Sep 18 | 73 | -74 | 36 | 0 |
30 Jun 18 | 84 | -66 | 36 | 0 |
31 Mar 18 | 75 | -66 | 36 | 0 |
31 Dec 17 | 66 | -16 | 34 | 0 |
30 Sep 17 | 43 | -28 | 27 | 0 |
30 Jun 17 | 19 | -60 | 24 | 0 |
31 Mar 17 | 21 | -92 | 21 | 0 |
31 Dec 16 | 20 | -147 | 21 | 0 |
30 Sep 16 | 21 | -165 | 26 | 0 |
30 Jun 16 | 34 | -137 | 28 | 0 |
31 Mar 16 | 32 | -109 | 28 | 0 |
31 Dec 15 | 32 | -100 | 27 | 0 |
30 Sep 15 | 38 | -84 | 22 | 0 |
30 Jun 15 | 23 | -82 | 22 | 0 |
31 Mar 15 | 24 | -72 | 22 | 0 |
31 Dec 14 | 20 | -67 | 22 | 0 |
30 Sep 14 | 39 | -40 | 27 | 0 |
30 Jun 14 | 62 | -35 | 30 | 0 |
31 Mar 14 | 63 | -39 | 30 | 0 |
31 Dec 13 | 63 | -52 | 31 | 0 |
30 Sep 13 | 41 | -98 | 31 | 0 |
30 Jun 13 | 27 | -96 | 26 | 0 |
Quality Earnings: HOFB.F is currently unprofitable.
Growing Profit Margin: HOFB.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HOFB.F is unprofitable, and losses have increased over the past 5 years at a rate of 8.7% per year.
Accelerating Growth: Unable to compare HOFB.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HOFB.F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14%).
Return on Equity
High ROE: HOFB.F has a negative Return on Equity (-259.32%), as it is currently unprofitable.